Related Experiment Video
Updated: May 13, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Hematological parameters and major adverse cardiovascular events: a prospective study in a Chinese population
Hongna Mu1, Xinyue Wang2, Xianghui Zhao1
1The Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of Gerontology of National Health Commission, P.R. China.
Insights
Hematological parameters like red blood cell count (RBC) and platelet count (PLT) can predict major adverse cardiovascular events (MACEs) in coronary artery disease patients. Elevated RDW-CV and lower BASO% are significant indicators of cardiovascular risk.
Area of Science:
- Cardiology
- Hematology
- Clinical Research
Background:
- Hematological parameters are easily accessible clinical tests.
- Emerging evidence suggests their role in cardiovascular risk prediction.
- Coronary artery disease (CAD) patients require reliable risk stratification tools.
Purpose of the Study:
- To investigate the association between baseline hematological parameters and major adverse cardiovascular events (MACEs).
- To identify specific hematological markers predictive of MACEs in Chinese patients with CAD.
Main Methods:
- Prospective study of 2,970 Chinese patients undergoing coronary angiography.
- Baseline measurement of hematological and biochemical indicators.
- Follow-up for MACEs (myocardial infarction, stroke, revascularization, all-cause mortality) over a median of 79 months.
- Univariate, multivariate Cox regression, and Kaplan-Meier analyses.
Main Results:
- 474 MACEs occurred during follow-up.
- Lower RBC, PLT, PCT, LYMPH%, and higher RDW-CV, RDW-SD, MONO%, NEUT% correlated with reduced survival.
- Elevated RDW-CV (HR 1.292) was a significant risk factor for MACE.
- Lower BASO% (HR 0.750) showed a protective effect.
- Significant associations were found for RDW-CV, BASO%, LYMPH%, PLT, and PCT with MACEs, including nonlinear correlations for PLT and PCT.
Conclusions:
- RDW-CV, BASO%, PLT, PCT, and LYMPH% are significantly associated with MACEs in CAD patients.
- These hematological parameters may serve as valuable predictors for cardiovascular risk.
- Accessible hematological markers can enhance risk assessment in coronary artery disease management.
Abstract:
Hematological parameters are among the most accessible and routinely performed clinical tests. Recent studies have gradually revealed their potential for risk prediction. This study aimed to assess the association between hematological parameters and major adverse cardiovascular events (MACEs) in patients with coronary artery disease. This prospective study included 2,970 Chinese participants who underwent coronary angiography, with hematological and biochemical indicators measured at baseline. MACEs, comprising myocardial infarction, stroke, revascularization, and all-cause mortality, were recorded during follow-up. Univariate and multivariate analyses were conducted to evaluate the relationship between the hematological parameters and MACEs. Over a median follow-up period of 79 months, 474 MACEs were documented. Kaplan-Meier analysis indicated that the participants with lower levels of RBC, PLT, PCT, LYMPH% and BASO%, as well as higher RDW-CV, RDW-SD, MONO% and NEUT%, exhibited reduced survival probability. Multivariate Cox regression analysis identified elevated RDW-CV as a significant risk factor for MACE (T3 HR, 1.292; 95% CI, 1.013-1.647; P=0.039), while lower BASO% demonstrated a protective effect (T3 HR, 0.750, 95 % CI: 0.591-0.953; P=0.018). LYMPH% also showed a significant association with MACEs. Additionally, nonlinear correlations were observed between PLT and PCT and MACEs. In conclusion, RDW-CV, BASO%, PLT, PCT and LYMPH% were closely associated with MACEs and may serve as potential predictors for cardiovascular risk in patients with coronary artery disease.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...

